One of the goals of the BeginNGS newborn genomic sequencing program is equitable access, according to Stephen Kingsmore, MD, DSc, president and CEO, Rady Children’s Institute for Genomic Medicine. He discusses the types of disparities seen in genetic testing as the phase 2 clinical trial is underway.
Menu